Skip to content
healthcare.dev

LORATADINE

NDC 72983-501, LORATADINE, tablet, orally disintegrating, from Tenshi Kaizen Pvt Ltd.

Product NDC
72983-501
Status
Listed
Labeler
Tenshi Kaizen Pvt Ltd
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213294
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72983-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
Package NDCNDC-11Package
72983-501-01729830501011 BLISTER PACK in 1 CARTON (72983-501-01) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
72983-501-03729830501033 BLISTER PACK in 1 CARTON (72983-501-03) / 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 72983-501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72983-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72983-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.